technologynetworks

JMP® Genomics 3.1 Adds new DNA Analysis Tools

JMP® Genomics 3.1, new from SAS, gives scientists important new tools in their quest to understand the causes of human disease. This all-in-one genomics software for the desktop now includes ...
Business Wire

JMP ® Clinical Adds Ways to Explore Clinical Trials Data Visually

CARY, N.C.--(BUSINESS WIRE)--JMP® Clinical 3, just released by business analytics leader SAS, offers new ways to interactively explore safety data in clinical trials, streamlining the review process ...

JMP reiterates Market Outperform rating on Caesars stock amid betting exchange analysis

Investing.com - JMP Securities has reiterated its Market Outperform rating and $41.00 price target on Caesars Entertainment (NASDAQ:CZR) stock, according to a research note published Friday. The ...
Investing

JMP reiterates Market Outperform rating on Larimar stock ahead of data

Investing.com - JMP Securities maintained its Market Outperform rating and $18.00 price target on Larimar Therapeutics (NASDAQ:LRMR) stock on Tuesday. According to InvestingPro data, analysts are ...
technologynetworks

SAS Integrates JMP® Software with Ingenuity Pathways Analysis

SAS and Ingenuity Systems have announced a partnership aimed at streamlining the discovery of important biological connections from high-throughput microarray experiments. Integration between JMP ...
Investing

JMP reiterates Market Outperform rating on Crinetics stock as paltusotine shows strong data

Investing.com - JMP Securities has reiterated its Market Outperform rating and $90.00 price target on Crinetics (NASDAQ:CRNX) following new long-term safety and efficacy data for its lead drug ...